Literature DB >> 9986856

Evaluation of the ultrasensitive Roche Amplicor HIV-1 monitor assay for quantitation of human immunodeficiency virus type 1 RNA.

M Erali1, D R Hillyard.   

Abstract

The ultrasensitive Amplicor HIV-1 Monitor test (Roche Diagnostic Systems) was evaluated for precision, linearity, and sensitivity and was compared to the standard Amplicor assay. The ultrasensitive assay reliably quantified samples in the range from 50 to 50,000 human immunodeficiency virus type 1 RNA copies/ml with acceptable correlation with the standard Amplicor test.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9986856      PMCID： PMC84558     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  4 in total

Review 1.  HIV viral load markers in clinical practice.

Authors:  M S Saag; M Holodniy; D R Kuritzkes; W A O'Brien; R Coombs; M E Poscher; D M Jacobsen; G M Shaw; D D Richman; P A Volberding
Journal:  Nat Med       Date:  1996-06       Impact factor: 53.440

2.  Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.

Authors:  J W Mellors; A Muñoz; J V Giorgi; J B Margolick; C J Tassoni; P Gupta; L A Kingsley; J A Todd; A J Saah; R Detels; J P Phair; C R Rinaldo
Journal:  Ann Intern Med       Date:  1997-06-15       Impact factor: 25.391

3.  Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS.

Authors:  W A O'Brien; P M Hartigan; E S Daar; M S Simberkoff; J D Hamilton
Journal:  Ann Intern Med       Date:  1997-06-15       Impact factor: 25.391

4.  Clinical comparison of an enhanced-sensitivity branched-DNA assay and reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma.

Authors:  F S Nolte; J Boysza; C Thurmond; W S Clark; J L Lennox
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948
  4 in total
  21 in total

1.  Multisite comparison of reproducibility and recovery from the standard and ultrasensitive Roche AMPLICOR HIV-1 MONITOR assays.

Authors:  D J Brambilla; S Granger; C Jennings; J W Bremer
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

2.  Pilot studies for development of an HIV subtype panel for surveillance of global diversity.

Authors:  Mark Manak; Silvana Sina; Bharathi Anekella; Indira Hewlett; Eric Sanders-Buell; Viswanath Ragupathy; Jerome Kim; Marion Vermeulen; Susan L Stramer; Ester Sabino; Piotr Grabarczyk; Nelson Michael; Sheila Peel; Patricia Garrett; Sodsai Tovanabutra; Michael P Busch; Marco Schito
Journal:  AIDS Res Hum Retroviruses       Date:  2012-02-24       Impact factor: 2.205

3.  A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies.

Authors:  Robert W Shafer; Kathryn Dupnik; Mark A Winters; Susan H Eshleman
Journal:  HIV Seq Compend       Date:  2001

4.  One-tube real-time isothermal amplification assay to identify and distinguish human immunodeficiency virus type 1 subtypes A, B, and C and circulating recombinant forms AE and AG.

Authors:  M P de Baar; E C Timmermans; M Bakker; E de Rooij; B van Gemen; J Goudsmit
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

5.  Cerebrospinal and peripheral human immunodeficiency virus type 1 load in a multisite, randomized, double-blind, placebo-controlled trial of D-Ala1-peptide T-amide for HIV-1-associated cognitive-motor impairment.

Authors:  Karl Goodkin; Benedetto Vitiello; William D Lyman; Deshratn Asthana; J Hampton Atkinson; Peter N R Heseltine; Rebeca Molina; Wenli Zheng; Imad Khamis; Frances L Wilkie; Paul Shapshak
Journal:  J Neurovirol       Date:  2006-06       Impact factor: 2.643

6.  Comparative performance of three viral load assays on human immunodeficiency virus type 1 (HIV-1) isolates representing group M (subtypes A to G) and group O: LCx HIV RNA quantitative, AMPLICOR HIV-1 MONITOR version 1.5, and Quantiplex HIV-1 RNA version 3.0.

Authors:  P Swanson; V Soriano; S G Devare; J Hackett
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

7.  Comparison of the LCx human immunodeficiency virus (HIV) RNA quantitative, RealTime HIV, and COBAS AmpliPrep-COBAS TaqMan assays for quantitation of HIV type 1 RNA in plasma.

Authors:  Vincent Foulongne; Brigitte Montes; Marie-Noelle Didelot-Rousseau; Michel Segondy
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

8.  Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT.

Authors:  Priscilla Swanson; Carmen de Mendoza; Yagnya Joshi; Alan Golden; Richard L Hodinka; Vincent Soriano; Sushil G Devare; John Hackett
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

9.  Evaluation of automated sample preparation and quantitative PCR LCx assay for determination of human immunodeficiency virus type 1 RNA.

Authors:  Zsofia Muller; Evelyn Stelzl; Michael Bozic; Josef Haas; Egon Marth; Harald H Kessler
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

10.  Monitoring virologic responses to antiretroviral therapy in HIV-infected adults in Kenya: evaluation of a low-cost viral load assay.

Authors:  Sumathi Sivapalasingam; Beatrice Wangechi; Fatuma Marshed; Maura Laverty; Shaffiq Essajee; Robert S Holzman; Fred Valentine
Journal:  PLoS One       Date:  2009-08-28       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.